Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

GeneDx Holdings Corp. (WGS) Stock Forecast 2025 - AI Price Prediction & Analysis

GeneDx Holdings Corp. (WGS) AI Stock Price Forecast & Investment Analysis

GeneDx Holdings Corp. Stock Price Chart and Technical Analysis

Loading GeneDx Holdings Corp. interactive price chart and technical analysis...

GeneDx Holdings Corp. (WGS) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

GeneDx Holdings Corp. (Stock Symbol: WGS) is a leading company in the Industrial Applications and Services sector , specifically operating within the Services-Health Services industry. The organization employs approximately 1200 professionals worldwide . The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Financial Performance & Key Metrics Analysis

Annual Revenue: $308 million generating a -38.1% net profit margin .

Market Capitalization: $2295 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for GeneDx Holdings Corp. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

GeneDx Holdings Corp. strategically competes in the highly dynamic Services-Health Services marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share . The company maintains a healthy 44.2% gross margin, indicating strong pricing power and operational efficiency.

GeneDx Holdings Corp. (WGS) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for GeneDx Holdings Corp. stock analysis.

Loading GeneDx Holdings Corp. comprehensive fundamental analysis and insider trading data...

Deep dive into GeneDx Holdings Corp.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if GeneDx Holdings Corp. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For GeneDx Holdings Corp.: With a P/E ratio of -19.26, the market sees the stock as potentially undervalued.

P/E Ratio -19.26x
P/B Ratio 8.91x
Market Cap $2295M
EPS $-2.90
Book Value/Share $9.02
Revenue/Share $9.05
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently GeneDx Holdings Corp. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For GeneDx Holdings Corp.:

Gross Margin 44.2%
Operating Margin -30.1%
Net Margin -38.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess GeneDx Holdings Corp.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For GeneDx Holdings Corp.:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal GeneDx Holdings Corp.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For GeneDx Holdings Corp.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively GeneDx Holdings Corp. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For GeneDx Holdings Corp.:

Understanding Financial Statement Data

What these metrics mean: Key figures from GeneDx Holdings Corp.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For GeneDx Holdings Corp.: With annual revenue of $308M, GeneDx Holdings Corp. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $308M
Operating Income $-57M
Net Income $-83M
R&D Expense $46M
Cost of Goods Sold $108M
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding 29M
Growth Metrics (YoY)
EPS Growth -4.7%

Latest GeneDx Holdings Corp. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting GeneDx Holdings Corp. (WGS) stock price and investment outlook.

📰 We are currently updating our news feed for GeneDx Holdings Corp.. Check back soon for the latest market analysis and company updates.

GeneDx Holdings Corp. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of GeneDx Holdings Corp. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ATPC Unlock Forecast $65M x 2.8x
DCGO Unlock Forecast $143M 15.5x 0.5x
EUDA Unlock Forecast $-103M -10.7x -17.5x
EUDAW Unlock Forecast $2M x -0.4x
INNV Unlock Forecast $584M -31.1x 2.5x
KDLY Unlock Forecast $83M x 54.4x
KDLYW Unlock Forecast $2M x 0.7x
LDDD Unlock Forecast $166M x 166.1x
LFST Unlock Forecast $2134M 0.0x 1.5x
NAKA Unlock Forecast $31M x 3.5x
NAKAW Unlock Forecast $38M x 4.2x
OMDA Unlock Forecast $1356M x 6.3x
PIII Unlock Forecast $0M -0.3x 0.0x
PIIIW Unlock Forecast $0M x 0.0x
PNTG Unlock Forecast $902M 33.6x 2.9x
PRVA Unlock Forecast $3186M 214.6x 4.7x
TALK Unlock Forecast $416M -81.9x 3.7x
TALKW Unlock Forecast $37M x 0.3x
USPH Unlock Forecast $1918M 50.3x 3.8x
VSEE Unlock Forecast $0M -1.3x -1.9x
VSEEW Unlock Forecast $0M x -0.1x
WGS Unlock Forecast $2295M -19.3x 8.9x
WGSWW Unlock Forecast $7M x 0.0x

Frequently Asked Questions - GeneDx Holdings Corp. Stock Forecast

How accurate are GeneDx Holdings Corp. stock predictions?

Our AI model demonstrates 37% historical accuracy for WGS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence GeneDx Holdings Corp. stock price forecasts?

Our analysis considers GeneDx Holdings Corp.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is GeneDx Holdings Corp. a good investment in 2025?

Based on our AI analysis, GeneDx Holdings Corp. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are GeneDx Holdings Corp. forecasts updated?

GeneDx Holdings Corp. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced GeneDx Holdings Corp. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for GeneDx Holdings Corp. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...